SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey

dc.contributor.authorOygar P.D.
dc.contributor.authorBüyükçam A.
dc.contributor.authorBal Z.Ş.
dc.contributor.authorDalgıç N.
dc.contributor.authorBozdemir Ş.E.
dc.contributor.authorKarbuz A.
dc.contributor.authorÇetin B.Ş.
dc.contributor.authorKara Y.
dc.contributor.authorÇetin C.
dc.contributor.authorHatipoğlu N.
dc.contributor.authorUygun H.
dc.contributor.authorAygün F.D.
dc.contributor.authorTörün S.H.
dc.contributor.authorOkur D.Ş.
dc.contributor.authorÇiftdoğan D.Y.
dc.contributor.authorKara T.T.
dc.contributor.authorYahşi A.
dc.contributor.authorÖzer A.
dc.contributor.authorDemir S.Ö.
dc.contributor.authorAkkoç G.
dc.contributor.authorTuran C.
dc.contributor.authorSalı E.
dc.contributor.authorŞen S.
dc.contributor.authorErdeniz E.H.
dc.contributor.authorKara S.S.
dc.contributor.authorEmiroğlu M.
dc.contributor.authorErat T.
dc.contributor.authorAktürk H.
dc.contributor.authorGürlevik S.L.
dc.contributor.authorSütçü M.
dc.contributor.authorAydın Z.G.G.
dc.contributor.authorAtikan B.Y.
dc.contributor.authorYeşil E.
dc.contributor.authorGüner G.
dc.contributor.authorÇelebi E.
dc.contributor.authorEfe K.
dc.contributor.authorİşançlı D.K.
dc.contributor.authorDurmuş H.S.
dc.contributor.authorTekeli S.
dc.contributor.authorKaraaslan A.
dc.contributor.authorBülbül L.
dc.contributor.authorAlmış H.
dc.contributor.authorKaba Ö.
dc.contributor.authorKeleş Y.E.
dc.contributor.authorYazıcıoğlu B.
dc.contributor.authorOğuz Ş.B.
dc.contributor.authorOvalı H.F.
dc.contributor.authorDoğan H.H.
dc.contributor.authorÇelebi S.
dc.contributor.authorÇakır D.
dc.contributor.authorKarasulu B.
dc.contributor.authorAlkan G.
dc.contributor.authorYenidoğan İ.
dc.contributor.authorGül D.
dc.contributor.authorKüçükalioğlu B.P.
dc.contributor.authorAvcu G.
dc.contributor.authorKukul M.G.
dc.contributor.authorBilen M.
dc.contributor.authorYaşar B.
dc.contributor.authorÜstün T.
dc.contributor.authorKılıç Ö.
dc.contributor.authorAkın Y.
dc.contributor.authorCebeci S.O.
dc.contributor.authorBucak I.H.
dc.contributor.authorYanartaş M.S.
dc.contributor.authorŞahin A.
dc.contributor.authorArslanoğlu S.
dc.contributor.authorElevli M.
dc.contributor.authorÇoban R.
dc.contributor.authorÖz Ş.K.T.
dc.contributor.authorHatipoğlu H.
dc.contributor.authorErkum İ.T.
dc.contributor.authorTurgut M.
dc.contributor.authorDemirbuğa A.
dc.contributor.authorÖzçelik T.
dc.contributor.authorÇiftçi D.
dc.contributor.authorSarı E.E.
dc.contributor.authorAkkuş G.
dc.contributor.authorHatipoğlu S.S.
dc.contributor.authorDinleyici E.Ç.
dc.contributor.authorHacımustafaoğlu M.
dc.contributor.authorÖzkınay F.
dc.contributor.authorKurugöl Z.
dc.contributor.authorCengiz A.B.
dc.contributor.authorSomer A.
dc.contributor.authorTezer H.
dc.contributor.authorKara A.
dc.date.accessioned2024-07-22T08:05:28Z
dc.date.available2024-07-22T08:05:28Z
dc.date.issued2021
dc.description.abstractBackground: Understanding SARS-CoV-2 seroprevalence among health care personnel is important to explore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. Methods: We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. Results: SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Conclusions: Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission. © 2021 The Author(s)
dc.identifier.DOI-ID10.1016/j.ijid.2021.09.054
dc.identifier.issn12019712
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13148
dc.language.isoEnglish
dc.publisherElsevier B.V.
dc.rightsAll Open Access; Gold Open Access
dc.subjectAntibodies, Viral
dc.subjectChild
dc.subjectCOVID-19
dc.subjectDelivery of Health Care
dc.subjectHealth Personnel
dc.subjectHumans
dc.subjectPandemics
dc.subjectSARS-CoV-2
dc.subjectSeroepidemiologic Studies
dc.subjectTurkey
dc.subjectimmunoglobulin G
dc.subjectimmunoglobulin M
dc.subjectSARS-CoV-2 antibody
dc.subjectvirus antibody
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectchild health care
dc.subjectcoronavirus disease 2019
dc.subjectCOVID-19 nucleic acid testing
dc.subjectcoworker
dc.subjectcross-sectional study
dc.subjectdemography
dc.subjectfemale
dc.subjectgeographic distribution
dc.subjecthealth care personnel
dc.subjecthealth survey
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmonitoring
dc.subjectnonhuman
dc.subjectnurse
dc.subjectpandemic
dc.subjectpediatric ward
dc.subjectphysician
dc.subjectpoint of care testing
dc.subjectrisk factor
dc.subjectseroprevalence
dc.subjectSevere acute respiratory syndrome coronavirus 2
dc.subjectTurkey (republic)
dc.subjectchild
dc.subjectepidemiology
dc.subjecthealth care delivery
dc.subjecthealth care personnel
dc.subjectseroepidemiology
dc.subjectturkey (bird)
dc.titleSARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey
dc.typeArticle

Files